How should DoD contractors prepare for potential annual audits of the TRICARE pharmacy contract over conflict-of-interest concerns? 2026

According to GSA guidelines, contractors must maintain documented conflict-of-interest controls, transparent financial relationships, and complete audit trails to be ready for annual TRICARE pharmacy contract reviews; the requirement affects prime contractors, pharmacy benefit managers (PBMs), retail and mail-order pharmacies, and subcontractors supporting DoD benefits. Per FAR clauses and TRICARE Manuals, contractors must declare organizational conflicts, update disclosures quarterly, and retain records for at least five years to demonstrate impartiality in formulary management, pricing, and beneficiary access. The SBA and OMB have underscored the need for small business participation without undue influence, while DoD oversight and GAO reporting emphasize monitoring and penalty provisions for lapses. Contractors should map employees and subsidiaries to conflict matrices, implement encrypted recordkeeping, and schedule internal compliance audits aligned to DoD/VA reporting cycles. Budgeting $25,000 to $150,000 for compliance tooling, policy updates, and third-party reviews is typical for firms scaling to manage TRICARE pharmacy scopes. Start compliance remediation at least 120 days before contract anniversaries to meet audit timelines and reduce risk of suspension or referral to debarment.

Per FAR 19.502, small businesses can pursue set-asides and mentor-protégé agreements while still complying with COI reporting, but they must document independence and financial separation in proposals and subcontracting plans. According to GSA guidelines, contractors must flow down COI mitigation clauses to subs and show evidence of monitoring. The SBA reports that 78% of small health contractors rely on prime partnerships to access federal pharmacy awards, so small firms should attach COI mitigation exhibits to proposals and retain signed disclosures for executives and clinical advisors. Under OMB M-25-21, agencies will expect transparency where algorithms or decision-support tools influence formulary or pricing choices, requiring decision logs and model documentation. DoD's CMMC framework requires protections for Controlled Unclassified Information (CUI) intersecting with beneficiary pharmacy data; firms processing electronic claims should implement CMMC Level 2 practices to reduce potential audit findings.

The SBA reports that 78% of small health contractors rely on prime partnerships to gain entry to federal pharmacy programs, which magnifies the need for prime-level COI controls and enforceable flow-down clauses in subcontract language. According to GSA guidelines, prime contractors must include explicit COI mitigation plans in their subcontracting plans and ensure segregation of duties where PBMs, wholesalers, or specialty pharmacies are involved. Per FAR 52.203-13 and FAR subpart 9.5, companies must disclose prior relationships, manage organizational conflicts, and implement monitoring procedures; the TRICARE Manuals add that pharmacy vendors must report compensation arrangements and rebates. Under OMB M-25-21, agencies will scrutinize third-party algorithms used for formulary placement and pricing to ensure no undisclosed incentives bias beneficiary access. DoD's CMMC and related IT security requirements mandate protected handling of claims and beneficiary data; auditors often flag insufficient logging and missing attestation as primary administrative weaknesses.

Under OMB M-25-21, agencies will prioritize transparency for third-party services that influence benefits or pricing; this affects contractors who supply pharmacy networks, PBM services, or formulary-design tools to TRICARE. According to GSA guidelines, contractors must provide a single point of contact for audit requests, document chains of custody for pricing and rebate submissions, and maintain an audit schedule for independent reviewers. Per GAO findings, DoD oversight has historically identified gaps in monitoring beneficiary access to prescription drugs, which increases congressional and inspector general attention on pharmacy COI. DoD’s TRICARE Manuals require specific disclosures for compensation and vendor relationships and instruct contractors on record retention and reporting cadence. DoD's CMMC expectations intersect with TRICARE because claims and utilization data are CUI when tied to beneficiaries; integrating CMMC controls with COI documentation reduces the likelihood of audit findings related to both data handling and conflict mitigation during GAO or DoD examinations.

DoD's CMMC framework requires access controls, logging, and incident response tied to systems that hold beneficiary prescriptions and claims; contractors should map those controls to TRICARE contract clauses. According to GSA guidelines, COI-related controls must be auditable: role-based access lists, encrypted retention, and immutable logs for pricing changes and formulary edits. Per FAR 9.5 and related contract clauses, contractors must produce conflict mitigation plans and evidence of monitoring by independent reviewers. The TRICARE Manuals add operational specifics—reporting formats, sample attestations, and timing for disclosures—which contractors should mirror in their internal policies. The SBA reports that lack of documentation—not necessarily substantive fraud—accounts for the majority of findings; therefore administrative readiness (timely signatures, versioned policies, and searchable logs) materially reduces risk in DoD annual TRICARE pharmacy reviews.

According to GSA guidelines, contractors must adopt a continuous-readiness posture: quarterly COI inventories, scheduled tabletop exercises, and retained attestation packets tied to contract anniversaries. Per FAR 52.203-13 and FAR subpart 9.5, map clauses to corporate policy and publish a single reconciliation document that links each contract clause to evidence (signed disclosure, training record, log entry). The SBA recommends small firms leverage mentor-protégé relationships for compliance capacity while maintaining clear firewalls and documented independence. Under OMB M-25-21, preserve algorithmic decision logs and model inputs where AI guides formulary or pricing to avoid algorithmic COI findings. Finally, DoD's CMMC expectations mean logs and role-based access controls should be implemented in production systems rather than patched on at audit time; treat security and COI evidence as a combined package for reviewers.